That is why one persons numbers should not become another persons benchmark
References Acosta, Andres, Alejandro Campos, Alan De la Rosa, Fauzi Feris, Wissam Ghusn, Lizeth Cifuentes, Maria Daniela Hurtado, and Daniel Sacoto Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity Hims & Hers Newsroom Hims & Hers is Delivering a New GLP-1
Lets start a conversation
Patients should monitor their symptoms closely and seek medical advice if aches persist or worsen
Aim for at least 150 minutes of moderate-intensity cardio weeklyabout 30 minutes on most days
If maximum average weight loss is your priority and you tolerate dual-agonists well, Tirzepatide may offer a stronger effect for some patients